Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.09 AUD | 0.00% | -4.26% | -37.93% |
Apr. 17 | Impedimed Implements Organizational Changes; Makes Strategy Chief, COO Redundant | MT |
Apr. 17 | Ord Minnett Starts ImpediMed at Speculative Buy, Price Target is AU$0.16 | MT |
Sales 2024 * | 10.87M 7.05M | Sales 2025 * | 19.14M 12.42M | Capitalization | 182M 118M |
---|---|---|---|---|---|
Net income 2024 * | -21M -13.63M | Net income 2025 * | -14M -9.09M | EV / Sales 2024 * | 14.5 x |
Net cash position 2024 * | 24.71M 16.03M | Net cash position 2025 * | 13.87M 9M | EV / Sales 2025 * | 8.79 x |
P/E ratio 2024 * |
-9.42
x | P/E ratio 2025 * |
-14.8
x | Employees | 76 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 85.74% |
Latest transcript on ImpediMed Limited
1 week | -4.26% | ||
Current month | -2.17% | ||
1 month | +2.27% | ||
3 months | -33.33% | ||
6 months | -30.77% | ||
Current year | -37.93% |
Managers | Title | Age | Since |
---|---|---|---|
Parmjot Bains
CEO | Chief Executive Officer | - | Jan. 07 |
McGregor Grant
DFI | Director of Finance/CFO | - | 23-09-27 |
Steven Chen
CTO | Chief Tech/Sci/R&D Officer | - | 23-09-25 |
Members of the board | Title | Age | Since |
---|---|---|---|
Parmjot Bains
CEO | Chief Executive Officer | - | Jan. 07 |
McGregor Grant
DFI | Director of Finance/CFO | - | 23-09-27 |
Chairman | - | 23-09-27 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 0.09 | 0.00% | 900,191 |
24-04-23 | 0.09 | 0.00% | 639,897 |
24-04-22 | 0.09 | -3.23% | 808,812 |
24-04-19 | 0.093 | -2.11% | 1,210,425 |
24-04-18 | 0.095 | +1.06% | 1,334,047 |
Delayed Quote Australian S.E., April 24, 2024 at 02:10 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-37.93% | 118M | |
+8.47% | 220B | |
+6.76% | 185B | |
+9.95% | 133B | |
+27.05% | 107B | |
-0.19% | 62.91B | |
+14.54% | 53.34B | |
-1.63% | 47.71B | |
-2.42% | 40.29B | |
+10.48% | 39.57B |
- Stock Market
- Equities
- IPD Stock